Clifford Swan Investment Counsel LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 15.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 57,518 shares of the healthcare conglomerate's stock after purchasing an additional 7,499 shares during the quarter. UnitedHealth Group comprises about 1.1% of Clifford Swan Investment Counsel LLC's investment portfolio, making the stock its 24th biggest position. Clifford Swan Investment Counsel LLC's holdings in UnitedHealth Group were worth $30,125,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group in the fourth quarter valued at about $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $30,000. IAG Wealth Partners LLC acquired a new position in UnitedHealth Group in the first quarter valued at approximately $42,000. Finally, Kapitalo Investimentos Ltda bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at $41,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at UnitedHealth Group
In other news, Director Kristen Gil acquired 3,700 shares of the firm's stock in a transaction dated Thursday, May 15th. The stock was bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director directly owned 3,818 shares in the company, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have acquired 109,408 shares of company stock valued at $31,607,768 in the last quarter. Insiders own 0.28% of the company's stock.
UnitedHealth Group Price Performance
UNH stock traded up $2.25 during trading on Monday, reaching $284.90. 1,278,294 shares of the company were exchanged, compared to its average volume of 7,795,977. The company has a 50-day moving average of $304.47 and a two-hundred day moving average of $432.39. The company has a market capitalization of $258.44 billion, a price-to-earnings ratio of 11.95, a P/E/G ratio of 1.38 and a beta of 0.45. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the previous year, the business posted $6.91 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.10%. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is 37.02%.
Analysts Set New Price Targets
A number of equities research analysts recently commented on the stock. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a report on Thursday. Oppenheimer lowered their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Robert W. Baird cut shares of UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price target on the stock. in a report on Wednesday, June 11th. Finally, TD Securities reissued a "hold" rating and issued a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $394.43.
Check Out Our Latest Stock Report on UnitedHealth Group
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
